Thursday, October 21, 2021

Third Dose of Pfizer/BioNTech Covid-19 vaccine 95.6% Effective: Study

The clinical phase three trial involved 10,000 participants 16 years of age and older.

from Top World News- News18.com https://ift.tt/3B2e8y8

No comments:

Post a Comment